{"AllianceGenome": "21637", "HGNC": "21637", "MIM": "608148", "_id": "23314", "_version": 1, "accession": {"genomic": ["AC016746.8", "AC017096.8", "AX027043.1", "CH471063.1", "CP068276.2", "KF456756.1", "NC_000002.12", "NC_060926.1", "NG_016976.2"], "protein": ["AAH98136.1", "AAH99723.1", "AAI03493.1", "AAI03501.1", "BAA82986.2", "BAB15073.1", "BAD92613.1", "BAF84152.1", "BAG51771.1", "CAC09123.1", "EAW70180.1", "EAW70181.1", "NP_001165980.1", "NP_001165988.1", "NP_056080.1", "Q9UPW6.2", "WES14201.1", "XP_005246453.1", "XP_047299731.1", "XP_054197095.1", "XP_054197096.1", "XP_054197097.1", "XP_054197098.1"], "rna": ["AB028957.1", "AB209376.1", "AJ438951.1", "AK025127.1", "AK056638.1", "AK291463.1", "BC098136.1", "BC099723.1", "BC103492.1", "BC103500.1", "NM_001172509.2", "NM_001172517.1", "NM_015265.4", "NR_134967.2", "OM752138.1", "XM_005246396.4", "XM_047443775.1", "XM_054341120.1", "XM_054341121.1", "XM_054341122.1", "XM_054341123.1"], "translation": [{"protein": "AAI03493.1", "rna": "BC103492.1"}, {"protein": "NP_001165980.1", "rna": "NM_001172509.2"}, {"protein": "BAF84152.1", "rna": "AK291463.1"}, {"protein": "AAI03501.1", "rna": "BC103500.1"}, {"protein": "XP_005246453.1", "rna": "XM_005246396.4"}, {"protein": "AAH98136.1", "rna": "BC098136.1"}, {"protein": "BAG51771.1", "rna": "AK056638.1"}, {"protein": "XP_047299731.1", "rna": "XM_047443775.1"}, {"protein": "WES14201.1", "rna": "OM752138.1"}, {"protein": "BAA82986.2", "rna": "AB028957.1"}, {"protein": "XP_054197098.1", "rna": "XM_054341123.1"}, {"protein": "XP_054197095.1", "rna": "XM_054341120.1"}, {"protein": "BAB15073.1", "rna": "AK025127.1"}, {"protein": "BAD92613.1", "rna": "AB209376.1"}, {"protein": "AAH99723.1", "rna": "BC099723.1"}, {"protein": "NP_056080.1", "rna": "NM_015265.4"}, {"protein": "XP_054197096.1", "rna": "XM_054341121.1"}, {"protein": "XP_054197097.1", "rna": "XM_054341122.1"}, {"protein": "NP_001165988.1", "rna": "NM_001172517.1"}]}, "alias": ["C2DELq32q33", "DEL2Q32Q33", "GLSS"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2020-09-15T16:00:00.000Z", "disease_label": "SATB2 associated disorder", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0100147", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_44d14081-fa32-4159-9049-35f510d2351a-2020-09-15T160000.000Z", "sop": "SOP7"}}, "ensembl": {"gene": "ENSG00000119042", "protein": ["ENSP00000260926", "ENSP00000388581", "ENSP00000388764", "ENSP00000401112", "ENSP00000405420", "ENSP00000415610", "ENSP00000514853", "ENSP00000514854", "ENSP00000514860", "ENSP00000514861"], "transcript": ["ENST00000260926", "ENST00000417098", "ENST00000428695", "ENST00000440919", "ENST00000443023", "ENST00000457245", "ENST00000463386", "ENST00000473517", "ENST00000483346", "ENST00000484124", "ENST00000700191", "ENST00000700192", "ENST00000700193", "ENST00000700194", "ENST00000700207", "ENST00000700208", "ENST00000700209", "ENST00000700210"], "translation": [{"protein": "ENSP00000401112", "rna": "ENST00000417098"}, {"protein": "ENSP00000388764", "rna": "ENST00000443023"}, {"protein": "ENSP00000260926", "rna": "ENST00000260926"}, {"protein": "ENSP00000514853", "rna": "ENST00000700191"}, {"protein": "ENSP00000514860", "rna": "ENST00000700208"}, {"protein": "ENSP00000514854", "rna": "ENST00000700193"}, {"protein": "ENSP00000388581", "rna": "ENST00000428695"}, {"protein": "ENSP00000405420", "rna": "ENST00000457245"}, {"protein": "ENSP00000514861", "rna": "ENST00000700210"}, {"protein": "ENSP00000415610", "rna": "ENST00000440919"}], "type_of_gene": "protein_coding"}, "entrezgene": "23314", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.9544789755, "exp_mis": 262.168378236, "exp_syn": 120.730935104, "lof_z": 4.64142428707304, "mis_z": 4.74779011139993, "mu_lof": 1.62144552287e-06, "mu_mis": 2.50800319248e-05, "mu_syn": 1.13711017771e-05, "n_lof": 0.0, "n_mis": 105.0, "n_syn": 129.0, "p_li": 0.99956300698079, "p_null": 1.40749824587054e-09, "p_rec": 0.000436991611711889, "syn_z": -0.466550296859993}, "bp": 2202, "cds_end": 200320760, "cds_start": 200136933, "n_exons": 10, "nonpsych": {"exp_lof": 19.6772036556, "exp_mis": 237.093969529, "exp_syn": 109.07942631, "lof_z": 4.35645890367259, "mis_z": 4.81832801209917, "mu_lof": 1.62144552287e-06, "mu_mis": 2.50800319248e-05, "mu_syn": 1.13711017771e-05, "n_lof": 0.0, "n_mis": 90.0, "n_syn": 117.0, "p_li": 0.999106203054569, "p_null": 9.81450255596803e-09, "p_rec": 0.000893787130928216, "syn_z": -0.477474527941946}, "nontcga": {"exp_lof": 20.1792390718, "exp_mis": 241.176043107, "exp_syn": 111.053580811, "lof_z": 4.43132550201668, "mis_z": 4.68941787291135, "mu_lof": 1.62144552287e-06, "mu_mis": 2.50800319248e-05, "mu_syn": 1.13711017771e-05, "n_lof": 0.0, "n_mis": 95.0, "n_syn": 115.0, "p_li": 0.999185375802828, "p_null": 6.407026319721e-09, "p_rec": 0.000814617790146027, "syn_z": -0.23711389866937}, "transcript": "ENST00000417098.1"}, "exons": [{"cdsend": 199456037, "cdsstart": 199272210, "chr": "2", "position": [[199269505, 199272672], [199308759, 199308957], [199323802, 199323958], [199328697, 199328910], [199348700, 199349173], [199368604, 199368707], [199380363, 199380487], [199381693, 199381820], [199433337, 199433514], [199455868, 199456096], [199457338, 199457939]], "strand": -1, "transcript": "NM_001172509", "txend": 199457939, "txstart": 199269505}, {"cdsend": 199456037, "cdsstart": 199272210, "chr": "2", "position": [[199269499, 199272672], [199308759, 199308957], [199323802, 199323958], [199328697, 199328910], [199348700, 199349173], [199368604, 199368707], [199380363, 199380487], [199381693, 199381820], [199433337, 199433514], [199455868, 199456096], [199460451, 199460532], [199464835, 199465108]], "strand": -1, "transcript": "NM_001172517", "txend": 199465108, "txstart": 199269499}, {"cdsend": 199456037, "cdsstart": 199272210, "chr": "2", "position": [[199269505, 199272672], [199308759, 199308957], [199323802, 199323958], [199328697, 199328910], [199348700, 199349173], [199368604, 199368707], [199380363, 199380487], [199381693, 199381820], [199433337, 199433514], [199455868, 199456096], [199460451, 199460532], [199471013, 199471266]], "strand": -1, "transcript": "NM_015265", "txend": 199471266, "txstart": 199269505}, {"cdsend": 199457939, "cdsstart": 199457939, "chr": "2", "position": [[199395830, 199397006], [199397529, 199397840], [199433337, 199433514], [199455868, 199456096], [199457338, 199457939]], "strand": -1, "transcript": "NR_134967", "txend": 199457939, "txstart": 199395830}], "exons_hg19": [{"cdsend": 200320760, "cdsstart": 200136933, "chr": "2", "position": [[200134228, 200137395], [200173482, 200173680], [200188525, 200188681], [200193420, 200193633], [200213423, 200213896], [200233327, 200233430], [200245086, 200245210], [200246416, 200246543], [200298060, 200298237], [200320591, 200320819], [200322061, 200322662]], "strand": -1, "transcript": "NM_001172509", "txend": 200322662, "txstart": 200134228}, {"cdsend": 200320760, "cdsstart": 200136933, "chr": "2", "position": [[200134222, 200137395], [200173482, 200173680], [200188525, 200188681], [200193420, 200193633], [200213423, 200213896], [200233327, 200233430], [200245086, 200245210], [200246416, 200246543], [200298060, 200298237], [200320591, 200320819], [200325174, 200325255], [200329558, 200329831]], "strand": -1, "transcript": "NM_001172517", "txend": 200329831, "txstart": 200134222}, {"cdsend": 200320760, "cdsstart": 200136933, "chr": "2", "position": [[200134228, 200137395], [200173482, 200173680], [200188525, 200188681], [200193420, 200193633], [200213423, 200213896], [200233327, 200233430], [200245086, 200245210], [200246416, 200246543], [200298060, 200298237], [200320591, 200320819], [200325174, 200325255], [200335736, 200335989]], "strand": -1, "transcript": "NM_015265", "txend": 200335989, "txstart": 200134228}, {"cdsend": 200322662, "cdsstart": 200322662, "chr": "2", "position": [[200260553, 200261729], [200262252, 200262563], [200298060, 200298237], [200320591, 200320819], [200322061, 200322662]], "strand": -1, "transcript": "NR_134967", "txend": 200322662, "txstart": 200260553}], "generif": [{"pubmed": 12915443, "text": "SATB2 is identified as the cleft palate gene on chromosome pair 2 which undergoes translocation."}, {"pubmed": 16327884, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16953426, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19668335, "text": "results suggest that deletion of SATB2 is responsible for several of the clinical features associated with 2q32q33 microdeletion syndrome"}, {"pubmed": 19937600, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20829881, "text": "SATB2 is upregulated in advanced HNSCC tumors and forms a stable complex with DeltaNp63alpha."}, {"pubmed": 21343628, "text": "this report provides further evidence that the SATB2 gene is the critical gene in this microdeletion syndrome."}, {"pubmed": 21677534, "text": "SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas."}, {"pubmed": 21965674, "text": "SATB2 as the first p63 binding partner that differentially influences AEC and EEC p63 mutant proteins"}, {"pubmed": 22570222, "text": "SATB2 may play a crucial role in protecting against oxidative stress-induced osteoblast apoptosis."}, {"pubmed": 22815795, "text": "SATB2 might involve in the development and progression of laryngeal squamous cell carcinoma."}, {"pubmed": 22825848, "text": "results establish SATB2 as a novel gamma-globin gene regulator and provide a glimpse of the differential and cooperative roles of SATB family proteins in modulating clustered genes transcription"}, {"pubmed": 23701429, "text": "SATB2 is a marker of osteoblastic differentiation in benign and malignant mesenchymal tumours."}, {"pubmed": 23925499, "text": "These findings indicate that SATB2 activates UPF3B expression through binding to its promoter."}, {"pubmed": 24316906, "text": "SATB2 immunostaining could potentially be a useful adjunct for assisting in the differential diagnosis of both benign and malignant osteogenic tumors and for colorectal adenocarcinomas"}, {"pubmed": 24363063, "text": "SATB2 and SOX9 may be acting together via complex cis-regulation to coordinate the growth of the developing jaw."}, {"pubmed": 24386467, "text": "Ectopic expression of SATB2 by transiently transfected with pCAG-SATB2 vector encoding the entire SATB2 coding sequence could reverse the effects of miR-31 on CRC tumorigenesis and progression."}, {"pubmed": 24411565, "text": "This contemporary review provides an exploration of the molecular characteristics and function of SATB2; including its expression and cytokine regulation, its involvement in human disease, and its potential roles in skeletogenesis."}, {"pubmed": 24437456, "text": "Data suggest that combined tumor expression of SATB2 (special AT-rich sequence binding protein 2) and CDH17 (cadherin-17) may be used as diagnostic biomarkers in subjects with medullary carcinoma of the large intestine (colon; cecum)."}, {"pubmed": 24565840, "text": "knockdown of SATB2 attenuated miR-31's osteogenic effects in mesenchymal stem cells"}, {"pubmed": 24884732, "text": "research showed that miR-182 could directly target the 3'untranslated region (3'UTR) of SATB2 mRNA and subsequently repress both the mRNA and protein expressions of SATB2, which we identified in previous studies as a CRC metastasis-associated protein"}, {"pubmed": 25118029, "text": "We here report on a girl with intellectual disability, nearly absent speech and suspected hypodontia who was shown to carry an intragenic SATB2 tandem duplication hypothesized to lead to haploinsufficiency of SATB2."}, {"pubmed": 25200657, "text": "The application of SATB2 to manipulate stem cells for the reconstruction of bone defects might represent a new approach."}, {"pubmed": 25220418, "text": "SATB2 as a novel regulator of Osteosarcoma invasion, in part via effects on EPLIN and the cytoskeleton."}, {"pubmed": 25251319, "text": "Intragenic duplication--a novel causative mechanism for SATB2-associated syndrome."}, {"pubmed": 25323550, "text": "Immunohistochemical expression of SATB1 and SATB2 was analysed in tissue microarrays with primary tumours and a subset of paired lymph node metastases from 175 patients operated with pancreaticoduodenectomy for periampullary adenocarcinoma."}, {"pubmed": 25523619, "text": "SATB2 action is mediated by palladin inhibition and the SATB2/palladin pathway is associated with invadopodia formation in colorectal cancer cells."}, {"pubmed": 25543122, "text": "This review will discuss the four major findings regarding SATB1/2 in colorectal cancer studies.[review]"}, {"pubmed": 25662172, "text": "Low SATB2 expression is associated with colorectal cancer."}, {"pubmed": 25755730, "text": "our data suggest that SATB2 plays an important role in esophageal squamous cell carcinoma progression, and that decreased expression of SATB2 in tumor tissues could be used as a prognostic marker for patients with esophageal squamous cell carcinoma."}, {"pubmed": 25885067, "text": "We provide supporting evidence that analysis for deletions or point mutations in SATB2 should be considered in children with intellectual disability and severely impaired speech, cleft or high palate, teeth abnormalities, and osteopenia."}, {"pubmed": 25888635, "text": "SATB2 is a direct target of miR-211. SATB2 expression was upregulated in hepatocellular cancer tissues and cell lines.  SATB2 rescued the miR-211-mediated inhibition of cell invasion and proliferation."}, {"pubmed": 25966365, "text": "Reduced SATB2 dosage leads to mRNA and microRNA expression patterns and DNA methylation patterns more characteristic of differentiating than proliferating neural stem cells. This balance change may underlie neurodevelopmental disorders."}, {"pubmed": 26039376, "text": "We found that IGFBP6 and SATB2 were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/AIDS patients while their promoters were predominantly hyper-methylated compared with normal controls."}, {"pubmed": 26097552, "text": "data suggest that SATB2 functions as a tumor suppressor in the development and progression of clear cell renal cell carcinoma"}, {"pubmed": 26261600, "text": "SATB2 is a sensitive marker for hindgut well-differentiated neuroendocrine tumors though it is not entirely specific."}, {"pubmed": 26508023, "text": "Overexpression of SATB2 repressed the expression of extracellular signal-regulated kinase 5 (ERK5), and activation of ERK5 restored the SATB2-induced inhibition of proliferation and migration in gastric cancer."}, {"pubmed": 26542609, "text": "SATB2 is frequently expressed in appendiceal mucinous neoplasms. In the context of a mucinous neoplasm involving the ovary, any SATB2 positivity should raise the possibility of appendiceal origin."}, {"pubmed": 26551622, "text": "Ovarian tumors with mucinous or endometrioid features that express SATB2 are unlikely to be of primary ovarian origin and more likely to be of colorectal/appendiceal origin."}, {"pubmed": 26701851, "text": "Low expression of SATB2 is associated with colorectal cancer."}, {"pubmed": 26714749, "text": "SATB2 regulates the mitosis of cell cycle and affects G1 cell cycle via interaction with CDK2."}, {"pubmed": 26780400, "text": "SATB2 expression increased anchorage-independent growth and cell migration in human bronchial epithelial cells"}, {"pubmed": 26785690, "text": "Data suggest that MIRN-33a-5p is highly induced by TNFa and BMP-2 in bone marrow stromal cells; anti-osteogenic TNFa down-regulates SATB2 expression indirectly; pro-osteogenic BMP-2 up-regulates SATB2 expression directly."}, {"pubmed": 27043339, "text": "Case Reports: cutaneous osteoblastic osteosarcomas positive for SATB2."}, {"pubmed": 27258560, "text": "this study shows that SATB2 is a diagnostic marker of sinonasal intestinal-type adenocarcinoma"}, {"pubmed": 27262585, "text": "this study shows that SATB2 can be used as an additional marker with similar sensitivity and specificity as CK20 for the diagnosis of Merkel cell carcinoma"}, {"pubmed": 27294605, "text": "SATB2 is a highly sensitive marker for osteosarcomatous differentiation in gynecologic tract"}, {"pubmed": 27393518, "text": "These results strongly suggest that SATB2 prevents induction of EMT by suppressing expression of EMT-inducing transcription factors in NSCLC cells."}, {"pubmed": 27409069, "text": "we report a exon frameshift mutation in SATB2 in a 15-year-old patient with cleft palate, apparent ID, mild facial dysmorphism, and low weight with additional features of osteoporosis, fractures, progressive tibial bowing, and scoliosis. it provides further evidence of a single-nucleotide, potentially dominant-negative SATB2 allele in association with phenotypes beyond those typically associated with deletion of the gene"}, {"pubmed": 27465835, "text": "Although SATB2 immunoexpression helps to distinguish osteosarcoma from their mimickers, the identification of malignant osteoid matrix formation and the integration of clinical and radiological data remain the corner stone of osteosarcoma diagnosis and as yet no antibody has equalled the diagnostic value of this important morphologic hallmark."}, {"pubmed": 27593563, "text": "these results suggest miR-31 inhibited triple negative breast cancer cells migration and invasion through suppressing SATB2 expression."}, {"pubmed": 27632702, "text": "our data reveal that SATB2 in alveolar bone mesenchymal stem cells (AB-BMSCs) associates with their age-related properties, and prevents AB-BMSCs senescence via maintaining Nanog expression."}, {"pubmed": 27784965, "text": "SATB2 can directly bind to the regulatory elements in the genetic loci of several stem cell markers and consequently inhibit the progression of CRC by negatively regulating stemness of CRC cells"}, {"pubmed": 28139846, "text": "We describe the phenotype and genotype of 12 individuals with 10 unique (de novo in 11 of 11 tested) pathogenic variants (1 splice site, 5 frameshift, 3 nonsense, and 2 missense) in SATB2 and review all cases reported in the published literature caused by point alterations thus far"}, {"pubmed": 28151491, "text": "features associated with de novo mutations affecting SATB2 function in individuals ascertained on the basis of intellectual disability"}, {"pubmed": 28211976, "text": "We describe here the identification of a de novo SATB2 point mutation in twin boys with cleft soft palate, dental anomalies, and development delay and compare the clinical presentation of SATB2 point mutation patients reported to date."}, {"pubmed": 28438615, "text": "Indicate that beta-catenin and SATB2 are useful immunohistochemical markers for differentiating between pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma."}, {"pubmed": 28667416, "text": "The study identified that decreased expression of SATB2 was correlated with tumor progression and poor prognosis in non-small cell lung cancer (NSCLC) patients. Furthermore, SATB2 suppressed lung cancer cell invasion and metastasis and regulated the expression of EMT-related proteins and histone methylation by G9a."}, {"pubmed": 28711650, "text": "SATB2 immunohistochemistry is not useful in supporting urothelial versus gastrointestinal or endocervical origin in the differential diagnosis of glandular lesions of the bladder/urinary tract."}, {"pubmed": 28787087, "text": "low BMD, fractures, and tibial bowing are relatively common skeletal complications in individuals with SAS. DXA is a useful tool when evaluating a child with SAS suspected to have low BMD and the results might alter clinical management."}, {"pubmed": 28914716, "text": "SATB2 is a useful marker for determining the primary sites of metastatic Krukenberg tumors of the ovary."}, {"pubmed": 28937318, "text": "our results strongly indicate that the crosstalk between p38 and Akt pathways can determine special AT-rich sequence-binding protein 2 expression and epithelial character of non-small-cell lung carcinoma cells"}, {"pubmed": 29084055, "text": "SATB2 and TLE1 Expression in BCOR-CCNB3 (Ewing-like) Sarcoma, Mimicking Small Cell Osteosarcoma and Poorly Differentiated Synovial Sarcoma."}, {"pubmed": 29196257, "text": "MiR-875-5pdirectly binds to the 3'untranslated region of SATB.2"}, {"pubmed": 29243296, "text": "HNF4-alpha and particularly SATB2 may be helpful in the differential diagnosis of pulmonary adenocarcinoma and metastases of colorectal adenocarcinomas"}, {"pubmed": 29317598, "text": "The Autism spectrum disorder candidate genes SATB2, CHD8 and EHMT1 show enriched expression in neurons, especially inhibitory neurons"}, {"pubmed": 29374710, "text": "The mRNA level of SATB2 was lower in tumor tissues than in samples of corresponding unchanged kidney. The results of the presented study suggest the tumor-suppressing function of SATB2."}, {"pubmed": 29396302, "text": "SATB2 could serve as a promising diagnostic biomarker of colorectal cancer metastases."}, {"pubmed": 29487003, "text": "SATB2 as an additional diagnostic marker for the diagnosis of an ovarian manifestation of low-grade appendiceal mucinous neoplasm"}, {"pubmed": 29566115, "text": "up-regulation of miR-31 may underlie endothelial dysfunction in diabetes by targeting Satb2"}, {"pubmed": 29924451, "text": "SATB2 can be used as a supplementary marker along with CDX2 to identify 'colon-rectum' as the primary site in material from patients presenting with metastasis."}, {"pubmed": 30001238, "text": "Loss of SATB2 expression is commonly seen in colorectal carcinoma with MMR protein deficiency and BRAF mutation."}, {"pubmed": 30040823, "text": "Study provides evidence that the molecular mechanisms that underpin schizophrenia and cognitive function include disruption of biological processes influenced by SATB2 as the brain is being organized and wired during development."}, {"pubmed": 30212392, "text": "SATB2 is a relatively specific immunohistochemistry marker for both metastatic and primary signet ring cell carcinomas of lower GI tract origin."}, {"pubmed": 30320357, "text": "miR-3666 was reported to be downregulated in CRC tissues and overexpression of miR-3666 impaired the proliferation, migration and invasion of CRC cells by targeting SATB2 in the present study."}, {"pubmed": 30511632, "text": "the associations between the cleft palate (CPO) and single nucleotide polymorphisms (SNPs) of special AT-rich sequence-binding protein 2 (SATB2), were investigated."}, {"pubmed": 30575289, "text": "this study has described the clinical and molecular features of three unrelated patients with de novo heterozygous SATB2 mutations. These patients exhibited similar clinical features that are associated with SAS."}, {"pubmed": 30627547, "text": "There was a negative correlation between the expression levels of SATB2 and miR-34a."}, {"pubmed": 30726206, "text": "A shift in the function of SATB2 in cortex over lifetime."}, {"pubmed": 30916759, "text": "review examines the molecular functions of SATB2 and miRNAs in the text of cancer development and potential strategies for cancer therapy with a focus on systemic miRNA delivery"}, {"pubmed": 30924313, "text": "data from the COEUR multicenter cohort demonstrate for the first time that SATB2 expression is an independent marker of ovarian endometrioid carcinoma patient survival and potentially of disease progression"}, {"pubmed": 30962505, "text": "SATB2 and CDX2-negative immunohistochemical expression is associated with reduced diseasespecific and disease-free survival in patients with mismatch repair protein deficient colonic adenocarcinomas."}, {"pubmed": 31021519, "text": "Study resume the 120 unique variants from unrelated families range from single nucleotide variations to complex genomic rearrangements involving the entire coding region of SATB2. While germline mosaicism has been found in some instances, most pathogenic variants have been confirmed to be de novo. Missense pathogenic variants are often found, and predicted to act as loss-of-protein function. [review]"}, {"pubmed": 31055823, "text": "Both sibs have carried partial deletion of SATB2 gene and had similar clinical phenotypes"}, {"pubmed": 31101576, "text": "Loss of expression of SATB2 is associated with poor differentiation of primary colon cancer and the formation of tumor deposits."}, {"pubmed": 31133441, "text": "SATB2 may be a viable marker of well differentiated neuroendocrine tumors of the rectum."}, {"pubmed": 31162297, "text": "SATB2 is also a susceptibility gene for schizophrenia in Uygur Chinese population."}, {"pubmed": 31233624, "text": "SATB2 is frequently and strongly expressed by lower GI tract neuroendocrine tumours (NETs); we have adopted it as our rectal NET marker."}, {"pubmed": 31318711, "text": "Loss of SATB2 expression is common in inflammatory bowel disease-associated colorectal dysplasia and adenocarcinoma."}, {"pubmed": 31420882, "text": "Behavioral phenotype and sleep problems in SATB2-associated syndrome."}, {"pubmed": 31602781, "text": "Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans."}, {"pubmed": 31728810, "text": "SATB2 and NRG1 overexpression induced many of the signaling pathways."}, {"pubmed": 32252013, "text": "SATB2 is frequently expressed in ossifying and non-ossifying peripheral oral fibroma of the gingival region but not in reactive fibromatous lesions from other intraoral sites."}, {"pubmed": 32345782, "text": "Long non-coding RNA H19 promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by regulating microRNA-140-5p/SATB2 axis."}, {"pubmed": 32446642, "text": "Epilepsy and Electroencephalographic Abnormalities in SATB2-Associated Syndrome."}, {"pubmed": 32484035, "text": "Role of Special AT-Rich Sequence-Binding Protein 2 in the Osteogenesis of Human Dental Mesenchymal Stem Cells."}, {"pubmed": 32504285, "text": "microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2."}, {"pubmed": 32914850, "text": "SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins."}, {"pubmed": 32946879, "text": "Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall."}, {"pubmed": 33124191, "text": "SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells."}, {"pubmed": 33168583, "text": "Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors."}, {"pubmed": 33173968, "text": "miR31 promotes tumorigenesis in ulcerative colitisassociated neoplasia via downregulation of SATB2."}, {"pubmed": 33309262, "text": "SATB2 is not a reliable diagnostic marker for distinguishing between oral osteosarcoma and fibro-osseous lesions of the jaws."}, {"pubmed": 33319920, "text": "SATB2-LEMD2 interaction links nuclear shape plasticity to regulation of cognition-related genes."}, {"pubmed": 33381861, "text": "Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2."}, {"pubmed": 33621956, "text": "Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K/AKT pathway."}, {"pubmed": 33661512, "text": "Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations."}, {"pubmed": 33675939, "text": "SATB2 overexpression promotes oral squamous cell carcinoma progression by up-regulating NOX4."}, {"pubmed": 33894556, "text": "Immunohistochemical expression and significance of SATB2 protein in colorectal cancer."}, {"pubmed": 33978159, "text": "SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors."}, {"pubmed": 34019815, "text": "A eutherian-specific microRNA controls the translation of Satb2 in a model of cortical differentiation."}, {"pubmed": 34074322, "text": "Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling."}, {"pubmed": 34080031, "text": "Long noncoding RNA HCG11 suppresses the malignant phenotype of nonsmall cell lung cancer cells by targeting a miR875/SATB2 axis."}, {"pubmed": 34109987, "text": "RUNX2/miR31/SATB2 pathway in nickelinduced BEAS2B cell transformation."}, {"pubmed": 34224081, "text": "SATB2 Immunoexpression in Peripheral Ossifying Fibroma and Peripheral Odontogenic Fibroma."}, {"pubmed": 34483137, "text": "Hsa-circ-0007292 promotes the osteogenic differentiation of posterior longitudinal ligament cells via regulating SATB2 by sponging miR-508-3p."}, {"pubmed": 34913369, "text": "Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall."}, {"pubmed": 34925645, "text": "Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for Lung Cancer Prognosis."}, {"pubmed": 35081869, "text": "Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer."}, {"pubmed": 35091815, "text": "SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix."}, {"pubmed": 35241104, "text": "SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients."}, {"pubmed": 35262524, "text": "SATB2 Immunopositivity in Spindle Cell (Sarcomatoid) Squamous Cell Carcinoma: A Potential Pitfall in Diagnosis."}, {"pubmed": 35311957, "text": "SATB2 Expression in Undifferentiated Pleomorphic Sarcomas of Bone."}, {"pubmed": 35405720, "text": "Association Between Loss of SATB2 Expression in Inflammatory Bowel Disease Indefinite for Dysplasia and a Diagnosis of Definitive Dysplasia on Follow-up."}, {"pubmed": 36148757, "text": "Exosome-delivered circSATB2 targets the miR-330-5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells."}, {"pubmed": 36517907, "text": "circ-Iqsec1 induces bone marrow-derived mesenchymal stem cell (BMSC) osteogenic differentiation through the miR-187-3p/Satb2 signaling pathway."}, {"pubmed": 36598364, "text": "YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma."}, {"pubmed": 36731037, "text": "Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas."}, {"pubmed": 36788065, "text": "Psammomatoid Ossifying Fibroma Is Defined by SATB2 Rearrangement."}, {"pubmed": 37107669, "text": "microRNA-660 Enhances Cisplatin Sensitivity via Decreasing SATB2 Expression in Lung Adenocarcinoma."}, {"pubmed": 37668387, "text": "SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors."}, {"pubmed": 37852859, "text": "Progress of epigenetic modification of SATB2 gene in the pathogenesis of non-syndromic cleft lip and palate."}, {"pubmed": 37877736, "text": "Single-cell sequencing reveals SATB2/NOTCH1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer."}, {"pubmed": 37984605, "text": "Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1."}, {"pubmed": 38244545, "text": "SATB2 organizes the 3D genome architecture of cognition in cortical neurons."}, {"pubmed": 38555678, "text": "Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers."}], "genomic_pos": {"chr": "2", "end": 199471266, "ensemblgene": "ENSG00000119042", "start": 199269505, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 200335989, "start": 200134223, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001764", "qualifier": "involved_in", "term": "neuron migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002076", "qualifier": "involved_in", "term": "osteoblast development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006338", "qualifier": "involved_in", "term": "chromatin remodeling"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009880", "qualifier": "involved_in", "term": "embryonic pattern specification"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 22825848, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048704", "qualifier": "involved_in", "term": "embryonic skeletal system morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051216", "qualifier": "involved_in", "term": "cartilage development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060021", "qualifier": "involved_in", "term": "roof of mouth development"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0000118", "qualifier": "part_of", "term": "histone deacetylase complex"}, {"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005667", "qualifier": "part_of", "term": "transcription regulator complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0016363", "qualifier": "located_in", "term": "nuclear matrix"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000977", "pubmed": 22825848, "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 22825848, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IEA", "id": "GO:0003682", "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [20829881, 25416956, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042826", "qualifier": "enables", "term": "histone deacetylase binding"}]}, "homologene": {"genes": [[7955, 563435], [8364, 100494002], [9031, 424063], [9544, 699151], [9598, 459856], [9606, 23314], [9615, 100687238], [9913, 541192], [10090, 212712], [10116, 501145]], "id": 32249}, "interpro": [{"desc": "Homeobox domain", "id": "IPR001356", "short_desc": "Homeobox_dom"}, {"desc": "CUT domain", "id": "IPR003350", "short_desc": "CUT_dom"}, {"desc": "Homeobox-like domain superfamily", "id": "IPR009057", "short_desc": "Homeobox-like_sf"}, {"desc": "Lambda repressor-like, DNA-binding domain superfamily", "id": "IPR010982", "short_desc": "Lambda_DNA-bd_dom_sf"}, {"desc": "SATB, CUT1-like DNA-binding domain", "id": "IPR032355", "short_desc": "CUTL"}, {"desc": "SATB, ubiquitin-like oligomerisation domain", "id": "IPR032392", "short_desc": "ULD"}, {"desc": "SATB, CUTL domain superfamily", "id": "IPR038216", "short_desc": "SATB_CUTL_sf"}, {"desc": "SATB, ULD domain superfamily", "id": "IPR038224", "short_desc": "SATB_ULD_sf"}, {"desc": "DNA-binding protein SATB1/SATB2", "id": "IPR039673", "short_desc": "SATB1/SATB2"}], "ipi": ["IPI00010433", "IPI00651702", "IPI00924512", "IPI00926670"], "map_location": "2q33.1", "name": "SATB homeobox 2", "other_names": ["DNA-binding protein SATB2", "SATB family member 2", "SATB2 fusion", "special AT-rich sequence-binding protein 2"], "pantherdb": {"HGNC": "21637", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2679336", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 10090, "uniprot_kb": "Q8VI24"}, {"RGD": "1562369", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 10116, "uniprot_kb": "D3ZJ19"}, {"Ensembl": "ENSGALG00000008135", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 9031, "uniprot_kb": "E1BZL3"}, {"ZFIN": "ZDB-GENE-070912-212", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 7955, "uniprot_kb": "E1ANH4"}, {"WormBase": "WBGene00022861", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 6239, "uniprot_kb": "Q86MI0"}, {"FlyBase": "FBgn0020307", "ortholog_type": "LDO", "panther_family": "PTHR15116", "taxid": 7227, "uniprot_kb": "Q9W268"}], "uniprot_kb": "Q9UPW6"}, "pathway": {"reactome": [{"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4551638", "name": "SUMOylation of chromatin organization proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8878166", "name": "Transcriptional regulation by RUNX2"}, {"id": "R-HSA-8940973", "name": "RUNX2 regulates osteoblast differentiation"}, {"id": "R-HSA-8941326", "name": "RUNX2 regulates bone development"}], "wikipathways": [{"id": "WP4312", "name": "Rett syndrome causing genes"}, {"id": "WP4533", "name": "Transcription co-factors SKI and SKIL protein partners"}]}, "pdb": ["1WI3", "1WIZ", "2CSF"], "pfam": ["PF00046", "PF02376", "PF16534", "PF16557"], "pharmgkb": "PA128394624", "pharos": {"target_id": 7609, "tdl": "Tbio"}, "prosite": ["PS50071", "PS51042", "PS51982", "PS51983"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF170062", "relationship": "is"}, {"id": "GNF180968", "relationship": "is"}, {"id": "GNF191874", "relationship": "is"}, {"id": "GNF202780", "relationship": "is"}, {"id": "GNF218305", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF042849", "relationship": "is"}, {"id": "GNF043817", "relationship": "is"}, {"id": "GNF043970", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF276490", "relationship": "is"}, {"id": "GNF276491", "relationship": "is"}, {"id": "GNF276509", "relationship": "is"}, {"id": "GNF276510", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF336890", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF116147", "relationship": "is"}, {"id": "GNF155788", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_016976.2"], "protein": ["NP_001165980.1", "NP_001165988.1", "NP_056080.1", "XP_005246453.1", "XP_047299731.1", "XP_054197095.1", "XP_054197096.1", "XP_054197097.1", "XP_054197098.1"], "rna": ["NM_001172509.2", "NM_001172517.1", "NM_015265.4", "NR_134967.2", "XM_005246396.4", "XM_047443775.1", "XM_054341120.1", "XM_054341121.1", "XM_054341122.1", "XM_054341123.1"], "translation": [{"protein": "XP_054197098.1", "rna": "XM_054341123.1"}, {"protein": "XP_054197096.1", "rna": "XM_054341121.1"}, {"protein": "XP_054197097.1", "rna": "XM_054341122.1"}, {"protein": "XP_054197095.1", "rna": "XM_054341120.1"}, {"protein": "NP_001165980.1", "rna": "NM_001172509.2"}, {"protein": "XP_047299731.1", "rna": "XM_047443775.1"}, {"protein": "NP_056080.1", "rna": "NM_015265.4"}, {"protein": "NP_001165988.1", "rna": "NM_001172517.1"}, {"protein": "XP_005246453.1", "rna": "XM_005246396.4"}]}, "reporter": {"HG-U133_Plus_2": ["213435_at", "215591_at"], "HG-U95Av2": "41708_at", "HTA-2_0": "TC02002656.hg.1", "HuEx-1_0": "2594089", "HuGene-1_1": "8058091", "HuGene-2_1": "16907044"}, "retired": [50820, 80104, 100190983], "summary": "This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and cognitive disability. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Feb 2010].", "symbol": "SATB2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1427665"}, "unigene": "Hs.516617", "uniprot": {"Swiss-Prot": "Q9UPW6", "TrEMBL": ["B3KPQ9", "Q59FT3", "A0A8V8TPF3", "F8WCV6", "A0A8V8TR16", "C9JR56"]}, "wikipedia": {"url_stub": "SATB2"}}